NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$4.84 and traded as high as C$4.93. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.92, with a volume of 529,976 shares traded.
Analyst Upgrades and Downgrades
Separately, National Bankshares increased their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 and gave the stock an "outperform" rating in a research report on Tuesday, March 11th.
Check Out Our Latest Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Stock Performance
The business's 50-day simple moving average is C$4.89 and its two-hundred day simple moving average is C$4.83. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The company has a market capitalization of C$1.21 billion, a PE ratio of -3.09, a PEG ratio of 0.74 and a beta of 1.05.
About NorthWest Health Prop Real Est Inv Trust
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Featured Articles
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.